Nevertheless, the presence of four SC and two S/beta+thalassemia patients in our case series, genotypes generally associated with lower hemolytic parameters and higher hemoglobin level, contrasts with this hypothesis and pleads for other pathophysiological combined factors or difference in sensitivity to EPO levels between patients. Here, EPO is linked to Beta-thalassemia.